BRIEF-Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology Portfolio

Reuters

Mar 06

BRIEF-Servier And <a href="https://laohu8.com/S/DAWN">Day One Biopharmaceuticals</a> Announce Acquisition To Expand Servier’S Rare Oncology Portfolio

March 6 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O:

SERVIER AND DAY ONE BIOPHARMACEUTICALS ANNOUNCE ACQUISITION TO EXPAND SERVIER’S RARE ONCOLOGY PORTFOLIO
DAY ONE BIOPHARMACEUTICALS INC - SERVIER TO BUY DAY ONE FOR $21.50 PER SHARE, TOTAL EQUITY VALUE $2.5 BILLION
DAY ONE BIOPHARMACEUTICALS INC - SERVIER EXPECTS TO FUND DEAL THROUGH EXISTING CASH AND INVESTMENTS

Source text: ID:nGNX1QNHQg

Further company coverage: DAWN.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2617638465"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2617638465\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2617638465?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 21:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617638465","market":"us","top_or_hot":-1,"title":"BRIEF-Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology Portfolio","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Servier And <a href=\"https://laohu8.com/S/DAWN\">Day One Biopharmaceuticals</a> Announce Acquisition To Expand Servier’S Rare Oncology Portfolio</title></head><body><p><span>March 6 (Reuters)</span><span> - </span>Day One Biopharmaceuticals Inc <span>DAWN.O</span>:</p><ul><li><p>SERVIER AND DAY ONE BIOPHARMACEUTICALS ANNOUNCE ACQUISITION TO EXPAND SERVIER’S RARE ONCOLOGY PORTFOLIO</p></li><li><p>DAY ONE BIOPHARMACEUTICALS INC - SERVIER TO BUY DAY ONE FOR $21.50 PER SHARE, TOTAL EQUITY VALUE $2.5 BILLION</p></li><li><p>DAY ONE BIOPHARMACEUTICALS INC - SERVIER EXPECTS TO FUND DEAL THROUGH EXISTING CASH AND INVESTMENTS</p></li></ul><p>Source text: <span>ID:nGNX1QNHQg</span></p><p>Further company coverage: <span>DAWN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology Portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-06 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Servier And <a href=\"https://laohu8.com/S/DAWN\">Day One Biopharmaceuticals</a> Announce Acquisition To Expand Servier’S Rare Oncology Portfolio</title></head><body><p><span>March 6 (Reuters)</span><span> - </span>Day One Biopharmaceuticals Inc <span>DAWN.O</span>:</p><ul><li><p>SERVIER AND DAY ONE BIOPHARMACEUTICALS ANNOUNCE ACQUISITION TO EXPAND SERVIER’S RARE ONCOLOGY PORTFOLIO</p></li><li><p>DAY ONE BIOPHARMACEUTICALS INC - SERVIER TO BUY DAY ONE FOR $21.50 PER SHARE, TOTAL EQUITY VALUE $2.5 BILLION</p></li><li><p>DAY ONE BIOPHARMACEUTICALS INC - SERVIER EXPECTS TO FUND DEAL THROUGH EXISTING CASH AND INVESTMENTS</p></li></ul><p>Source text: <span>ID:nGNX1QNHQg</span></p><p>Further company coverage: <span>DAWN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DAWN","symbol_name":"Day One Biopharmaceuticals Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nTUA7L63T6:1","article_id":"2617638465","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617638465","pubTimestamp":1772803887,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology PortfolioMarch 6 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O:SERVIER AND DAY ONE BIOPHARMACEUT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DAWN":"Day One Biopharmaceuticals Inc.","BK4539":"次新股","BK4139":"生物科技"},"translate_title":"简介-施维雅和Day One Biopharmaceuticals宣布收购以扩大施维雅的罕见肿瘤产品组合","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DAWN":0.9},"content_text":"BRIEF-Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology PortfolioMarch 6 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O:SERVIER AND DAY ONE BIOPHARMACEUTICALS ANNOUNCE ACQUISITION TO EXPAND SERVIER’S RARE ONCOLOGY PORTFOLIODAY ONE BIOPHARMACEUTICALS INC - SERVIER TO BUY DAY ONE FOR $21.50 PER SHARE, TOTAL EQUITY VALUE $2.5 BILLIONDAY ONE BIOPHARMACEUTICALS INC - SERVIER EXPECTS TO FUND DEAL THROUGH EXISTING CASH AND INVESTMENTSSource text: ID:nGNX1QNHQgFurther company coverage: DAWN.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}